Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sharon Kiang

Vascular Surgery Los Angeles, CA Medical Doctor

NPI 1952572737 CMS profile 1286706

200 Ucla Medical Plz Ste 526, Los Angeles, CA 90095

Open in the dashboard

General payments

$46,367

143 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sharon Kiang of Los Angeles, CA is reported in the CMS Open Payments database as having received $46,367 across 143 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $10,431 17
2024 General $14,978 20
2023 General $13,964 25
2022 General $3,548 15
2021 General $1,257 27
2020 General $211 4
2019 General $1,978 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharon Kiang
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Sharon Kiang were reported at $10,431. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Sharon Kiang Vascular Surgery median Middle half National median
2019 $1,978 $796 $226–$2,363 $163
2020 $211 $348 $118–$1,110 $114
2021 $1,257 $471 $158–$1,421 $132
2022 $3,548 $725 $222–$2,183 $149
2023 $13,964 $836 $257–$2,440 $160
2024 $14,978 $909 $252–$2,619 $164
2025 $10,431 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $32,471 44 payments
  2. Bolton Medical Inc $5,919 9 payments
  3. Endologix, Inc. $3,990 30 payments
  4. Shockwave Medical, Inc $1,568 17 payments
  5. Silk Road Medical, Inc. $1,164 10 payments
  6. Abbott Laboratories $583 20 payments
  7. Boston Scientific Corporation $167 1 payment
  8. Cook Medical LLC $157 5 payments
  9. Aidoc Medical Ltd $120 1 payment
  10. Bard Peripheral Vascular, Inc. $87 1 payment
  11. Other $142 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $31,337 16 payments
  2. Travel and Lodging $8,170 18 payments
  3. Food and Beverage $6,694 108 payments
  4. Grant $167 1 payment
Products named General payments · program years 2019–2025
  1. GORE EXCLUDER Iliac Branch Endoprosthesis $25,482 20 payments
  2. EXCLUDER Conformable AAA Endoprosthesis with Active Control $23,707 18 payments
  3. GORE VIABAHN VBX Balloon Expandable Endo $18,871 15 payments
  4. GORE VIABAHN Endoprosthesis with Heparin $12,966 9 payments
  5. GORE-TEX Vascular Graft $8,663 5 payments
  6. GORE TAG Conformable Thoracic Stent Graft $8,567 8 payments
  7. GORE VIABAHN Endoprosthesis $7,650 3 payments
  8. VIABAHN Endoprosthesis with PROPATEN Bioactive Surface $7,505 5 payments
  9. GORE EXCLUDER AAA Endoprosthesis $7,366 3 payments
  10. GORE TAG Thoracic Branch Endoprosthesis $7,352 3 payments
  11. Other $16,373 142 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

143 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record